深 沪
undefined undefined
--
NaN.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 振 幅 NaN.00%
- 最 低 --
- 昨 收 --
- 成交额 --
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Precision Oncology Approaches Drive $312B Market Transformation
USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, Oct. 17, 2025 /PRNewswire/ -- USA News Group News Commentary – Biomarker-driven drug development accelerates ...
10-17 21:00
A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts
In the preceding three months, 4 analysts have released ratings for Adaptive Bi...
10-01 04:00
Lilly's Jaypirca Demonstrates Significant Improvement In Progression-Free Survival Versus Chemoimmunotherapy In Phase 3 BRUIN CLL-313 Study
In the Phase 3 BRUIN CLL-313 study, treatment with pirtobrutinib demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival versus bendamustine plus rituximab,
09-08 18:47
AstraZeneca and AbbVie: New Phase II Study Targets Relapsed CLL/SLL
AstraZeneca (($AZN)), Abbvie (($ABBV)) announced an update on their ongoing cli...
09-08 00:58
BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients
BeOne Medicines reported positive Phase 1/2 results for sonrotoclax in relapsed or refractory mantle cell lymphoma, with regulatory submissions underway and a Phase 3 trial in progress.
08-29 22:16
中金：维持亚盛医药-B跑赢行业评级 升目标价至105港元
中金发布研报称，维持亚盛医药-B（06855）2025年/2026年归母净利润预测不变，维持跑赢行业评级，考虑到GLORA-4进展，新适应症空间可见度提升...
08-25 12:09
恒瑞医药上半年营收、净利创新高，恒生医疗ETF(513060)、港股创新药精选ETF(520690)拉升涨超1%
截至2025年8月21日09:47，恒生医疗保健指数(HSHCI)强势上涨1.86%，成分股平安好医生(01833)上涨7.69%，丽珠医药(01...
08-21 09:53
亚盛医药-B早盘涨超9% 利生妥治疗中高危MDS III期临床研究获美国FDA和欧洲EMA批准
亚盛医药-B（06855）早盘高开，股价上涨9.23%，现报94.05港元，创历史新高，成交额1.802亿港元。 亚盛医药公告，公司自主研发的Bcl-2选择...
08-18 09:43
Eli Lilly Co. Q2 FY2025 Earnings Transcript
Eli Lilly delivered a strong Q2 2025 with 38% revenue growth and major clinical milestones, despite a selloff over obesity drug trial data.
08-08 01:44
